Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Dual-antibody drug

Founded in 2012, Akeso is a biopharmaceutical company integrating the R&D, production and commercialization of innovative new antimicrobial drugs.

FAST NEWS: Akeso raises $247 million through share placement

The Latest: Akeso Inc. (9926.HK) announced Sunday it has entered into placement agreements to issue 31.7 million shares to six investors priced at HK$61.28 per share, representing a 4.99% discount…
October 14, 2024
9926.HK

Recent Articles

Founded in 2012, Akeso is a biopharmaceutical company integrating the R&D, production and commercialization of innovative new antimicrobial drugs.
October 14, 2024

FAST NEWS: Akeso raises $247 million through share placement

9926.HK

RELATED ARTICLES

  1. Everest's nefecon included on national drug list
    December 2, 2024
    Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  2. December 11, 2024
    BRIEF: Robosense raises HK$270 million in share placement at 8% discount
    2498.HK
  3. January 28, 2025
    BRIEF: China Ruyi raises $500 million in share placement at slight discount
    0136.HK
  4. December 3, 2024
    BRIEF: MicroPort MedBot raises $35 million in share placement at 20% discount
    2252.HK
  5. February 20, 2025
    BRIEF: Ubtech raises $113 million in fourth post-IPO share placement
    9880.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.